Previous Article | Next Article 
Mol Cell Biol, January 1998, p. 30-38, Vol. 18, No. 1
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Proteasome Inhibitors Cause Induction of Heat Shock Proteins and
Trehalose, Which Together Confer Thermotolerance in
Saccharomyces cerevisiae
Do Hee
Lee and
Alfred L.
Goldberg*
Department of Cell Biology, Harvard Medical
School, Boston, Massachusetts 02115
Received 20 March 1997/Returned for modification 24 April
1997/Accepted 30 September 1997
 |
ABSTRACT |
An accumulation in cells of unfolded proteins is believed to be the
common signal triggering the induction of heat shock proteins (hsps).
Accordingly, in Saccharomyces cerevisiae, inhibition of protein breakdown at 30°C with the proteasome inhibitor MG132 caused
a coordinate induction of many heat shock proteins within 1 to 2 h. Concomitantly, MG132, at concentrations that had little or no effect
on growth rate, caused a dramatic increase in the cells' resistance to
very high temperature. The magnitude of this effect depended on the
extent and duration of the inhibition of proteolysis. A similar
induction of hsps and thermotolerance was seen with another proteasome
inhibitor, clasto-lactacystin
-lactone, but not with an
inhibitor of vacuolar proteases. Surprisingly, when the reversible
inhibitor MG132 was removed, thermotolerance decreased rapidly, while
synthesis of hsps continued to increase. In addition, exposure to MG132
and 37°C together had synergistic effects in promoting
thermotolerance but did not increase hsp expression beyond that seen
with either stimulus alone. Although thermotolerance did not correlate
with hsp content, another thermoprotectant trehalose accumulated upon
exposure of cells to MG132, and the cellular content of this
disaccharide, unlike that of hsps, quickly decreased upon removal of
MG132. Also, MG132 and 37°C had additive effects in causing trehalose
accumulation. Thus, the resistance to heat induced by proteasome
inhibitors is not just due to induction of hsps but also requires a
short-lived metabolite, probably trehalose, which accumulates when
proteolysis is reduced.
 |
INTRODUCTION |
Exposure of cells or organisms to
elevated temperatures triggers the synthesis of heat shock proteins
(hsps), which help protect cells against high temperatures and a
variety of other potentially toxic agents (39, 51). Many of
these hsps function as molecular chaperones that help prevent the
accumulation of unfolded or aggregated polypeptides (21). In
growing cells, the hsps catalyze the proper folding of nascent
polypeptide chains, and upon heat shock, these chaperones prevent
protein aggregation and promote the refolding of damaged polypeptides
(15). Another important function of certain hsps is to
promote the rapid degradation of such abnormal proteins (28, 32,
47). In eukaryotes, ubiquitin and certain ubiquitin-conjugating
enzymes are hsps that function in the rapid breakdown of denatured
proteins (39). In addition, certain molecular chaperones
have been shown to serve as cofactors in the selective degradation of
abnormal polypeptides (28, 32).
The induction of heat shock response can lead to increased tolerance of
cells to otherwise lethal, high temperatures. For example, when yeast
cells growing at 25°C are shifted to an intermediate temperature,
e.g., 37°C, to cause induction of hsps, the fraction of cells able to
survive a subsequent exposure to 50°C increases markedly. This
increase in thermotolerance is generally believed to require the
induction of hsps (39), although this requirement has been
questioned (3, 20, 48). The induction of the heat shock
response can also protect cells against a variety of other toxic
insults, such as ethanol and hydrogen peroxide (42, 49). In
fact, in experimental animals, the exposure to 42°C to induce hsps
has been shown to protect heart and brain against subsequent anoxic
injury (36). Consequently, there has been appreciable medical interest in the possibility of inducing this response in
patients. Because elevating body temperatures is an inconvenient and
potentially dangerous procedure, the identification of pharmacological agents that could elicit this protective response would be highly desirable.
Hsps are also induced by a variety of other insults to the cell, such
as ethanol, heavy metals, and oxidants (42). One common feature of these various conditions is that they damage or denature cell proteins. Other treatments that prevent the proper folding of
newly synthesized proteins (e.g., incorporation of amino acid analogs)
or introduction of unfolded proteins into bacterial or vertebrate cells
also causes the induction of hsps (1, 22, 40). Thus, it is
widely believed that the common feature of the various conditions that
elicit this response is the accumulation of abnormal polypeptides in
cells. Similarly, it is now well established that the accumulation of
unfolded proteins in the endoplasmic reticulum (ER) signals the
induction of many ER-specific molecular chaperones (8, 35).
The cells' capacity to degrade rapidly such unfolded proteins is
therefore likely to be one important determinant influencing the
expression of hsps. The major pathway for the selective degradation of
abnormal proteins in the cytosol and nucleus is the
ubiquitin-proteasome pathway (7, 18). A failure of function
of this degradative system should lead to the induction of hsps. In
fact, increased thermotolerance was observed in a yeast mutant in which
genes encoding the ubiquitin-conjugating enzymes UBC4 and UBC5 were deleted (45).
A major goal of the present study was to test whether pharmacological
agents that block proteasome function, by causing an accumulation of
abnormal proteins, might increase the expression of hsps and
thermotolerance. The magnitude and rapidity of such a response should
depend on the extent of inhibition of protein breakdown and the
frequency of production of abnormal polypeptides in normal cells.
Recently, several selective inhibitors of the proteasome that can enter
mammalian cells and inhibit the ubiquitin-proteasome pathway (e.g., the
reversible peptide aldehydes such as MG132 or the irreversible
modifiers lactacystin and clasto-lactacystin
-lactone)
have been identified (11, 14, 25, 41). Certain of these
inhibitors also selectively block the degradation of short-lived and
abnormal proteins in intact Saccharomyces cerevisiae cells
(31). In yeast cells, unlike in mammalian cells, these proteasome inhibitors do not affect the breakdown of bulk of cell proteins, which are long-lived and degraded in the vacuole
(31). In related studies of MDCK cells, we have recently
found that exposure to proteasome inhibitors can cause an induction of
hsps (4). The present study of yeast not only establishes
the generality of this effect but also systematically investigated the
mechanism of this response and its physiological consequences. We
demonstrate here that proteasome inhibitors at concentrations that do
not appear harmful, through their inhibition of protein degradation, cause an induction of hsps in yeast and concomitantly cause an increase
in the cells' resistance to high temperature. However, this protection
against high temperature could not be explained simply by the buildup
of hsps. We present evidence that proteasome inhibitors also cause the
accumulation of another thermoprotectant molecule, the disaccharide
trehalose, whose content correlates with the cells' resistance to high
temperature.
 |
MATERIALS AND METHODS |
Measurement of the synthesis of hsps.
The S. cerevisiae ise1 strain used in this study, which is permeable to
several proteasome inhibitors (31), is JN 284 (MAT
his7 leu2 ura3 ise1; kindly provided by J. C. Wang, Harvard
University). This strain was grown exponentially in methionine-free
glucose minimal (SD) medium at 30°C. At different times after
exposure to the proteasome inhibitors, the cells were incubated with
200 µCi of [35S]methionine (Tran35S-label;
1,000 Ci/mmol; ICN) for 5 or 30 min. Preparation of cell extracts and
immunoprecipitation were carried out as described previously
(32).
Measurement of protein breakdown in vivo.
The
ise1 cells grown exponentially in methionine-free SD medium
were incubated with proteasome inhibitors or phenylmethylsulfonyl fluoride (PMSF) for 90 min prior to labeling. These cells were then
labeled for 5 min with 100 µCi of [35S]methionine.
After two washes, cells were resuspended in fresh SD medium containing
methionine (0.5 mg/ml) and cycloheximide (0.5 mg/ml) to prevent
reincorporation of radioactive amino acids released from proteins. At
different time intervals, aliquots of cells were taken and mixed with
100% trichloroacetic acid to give a final concentration of 10%. After
incubation at 4°C for 1 h, the samples were centrifuged, and the
radioactivity in the trichloroacetic acid-insoluble material
(precipitates) was measured. The rate of protein degradation is
expressed as the percentage of incorporated radioactivity that is
converted into acid-soluble fragments from the cells during the chase
period (means ± standard deviations [SD]).
Assay of cell resistance to heat.
Thermotolerance assays
were carried out as described elsewhere (44), with some
modifications. Prior to heat treatment, ise1 cells growing
exponentially at 30°C in SD medium were incubated with proteasome
inhibitors for 2 h (except in Fig. 3C) and then shifted to 52°C
for the indicated time. Cells were then diluted 200-fold and plated
onto YPD medium to determine the number of viable colonies.
Extraction and assay of trehalose.
Trehalose was extracted
from yeast cells and assayed as described previously (29),
with some modifications. Exponentially growing yeast cells were
collected by centrifugation and then washed twice in cold water to
remove free glucose. Cells were resuspended in 10 to 20 volumes of
ice-cold water and incubated at 95°C for 20 min, and then the
supernatant was collected by centrifugation. The amount of trehalose
was measured by treatment of this supernatant with trehalase (20 mU/sample; Sigma Chemical Co.), which hydrolyzes trehalose to glucose.
After 6 to 8 h of incubation at 37°C, the amount of glucose
generated was assayed with a glucose assay kit (Sigma) containing
hexokinase and glucose-6-phosphate dehydrogenase. The preexistent
glucose in each sample (usually less than 5% of the amount generated
by trehalase) was assayed in a parallel tube without trehalase and was
subtracted from total glucose. The total amount of proteins in each
sample was also measured by the Bradford method (Pierce) for the
calibration. The cellular content of trehalose was expressed as the
nanomoles of trehalose per microgram of cell protein.
 |
RESULTS |
Induction of hsps by the inhibitor of proteasome.
To test
whether the inhibition of proteasome function influences the synthesis
of various hsps, yeast cells growing at 30°C were exposed to
[35S]methionine for a 30-min pulse in the presence or
absence (dimethyl sulfoxide [DMSO] control) of a potent inhibitor of
proteasomes, MG132 (Cbz-LLLal). We then measured the rates of
incorporation of 35S into four different hsps (hsp104,
hsp70, Ydj1p, and Sis1p) after isolation of each by
immunoprecipitation. Because these inhibitors fail to penetrate into
wild-type cells (31), we used an ise1 permeability mutant strain (38). Upon incubation with 50 µM MG132, [35S]methionine incorporation into all of
these hsps increased within 1 h and continued to increase linearly
for 3 h (Fig. 1). Synthesis of
hsp104 showed the largest relative increase (three- to fourfold) after
exposure to MG132. The DnaJ homologs Ydj1p and Sis1p also showed a 2- to 3-fold increase in synthetic rates, while incorporation into hsp70
seemed to rise only 1.5- to 2-fold, perhaps because the antibody used
cannot distinguish the heat-inducible species from the several
constitutive species of hsp70 (Fig. 1). These findings clearly indicate
steadily increasing rates of labeling of multiple hsps during a 30-min
pulse of [35S]methionine with longer exposure to MG132.
To ensure that these findings represent increased rates of synthesis
and are not complicated by changes in degradation of the labeled hsps
in the presence of MG132, cells were exposed to MG132 for 2 h and
then to the 5-min pulse of [35S]methionine. The data
shown in Fig. 1C also indicated two- to threefold more rapid labeling
of hsps under these conditions. Control studies showed that MG132 did
not stimulate the synthesis of these hsps in wild-type yeast, where
this agent does not penetrate and thus cannot affect protein breakdown
(data not shown). Therefore, these data must reflect increased rates of
synthesis and cannot be explained by the inhibitor's preventing
degradation of hsps (especially since hsps are rather stable proteins).
Also, these findings are in accord with observation in mammalian cells,
where this inhibitor causes hsp accumulation through enhanced gene
expression (4, 52).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 1.
MG132 increases the synthesis of hsps in yeast cells.
ise1 cells were incubated during growth at 30°C with
either 50 µM MG132 (dissolved in DMSO) or 0.1% DMSO (control). (A)
The rates of synthesis of several hsps (hsp104, hsp70, Ydj1p, and
Sis1p) were then measured by pulse-labeling cells with 200 µCi of
[35S]methionine for 30 min at different times. Shown are
the times at the end of the 30-min pulse (1, 2, or 3 h after MG132
was added). After cell lysis, immunoprecipitation with antibodies
against these hsps was performed with equal amounts of radioactive
proteins in control or MG132-treated cells. (B) Relative induction
rates of these four hsps based on data in panel A. Data shown are the
mean values ± SD from three independent experiments. (C) To show
that these effects of MG132 were due to enhanced synthesis of hsps, the
ise1 cell were incubated with either 50 µM MG132 or 0.1%
DMSO (control) for 2 h and then labeled with 200 µCi of
[35S]methionine for 5 min. The synthesis of hsp70, Ydj1p,
and Sis1p was measured as for panel A.
|
|
Proteasome inhibitor induces hsps without reducing cell
growth.
Most treatments that cause induction of hsps (e.g.,
incorporation amino acid analogs, puromycin, or heavy metals) are
themselves harmful to cells and can rapidly reduce growth rate or
viability. Surprisingly, MG132, at concentrations that caused induction
of hsps, had no or very little effect on the growth of yeast at 30°C (Fig. 2). Incubation of growing cells
with increasing concentrations of MG132 (20 to 100 µM) for 2 h
did not significantly reduce the number of colonies on YPD plates (Fig.
2A), even though this agent caused a marked inhibition of intracellular
proteolysis (Fig. 3B). Also, in liquid
cultures, exposure to 50 µM MG132 did not reduce cell growth for
3 h, and by 24 h, the optical density of the treated culture
was only 15 to 30% lower than that in the control (Fig. 2B). These
experiments all used the ise1 strain, whose growth rate was
about 50% lower than those of typical wild-type strains, e.g., W303
(data not shown), presumably because of the defect in its cell membrane
(19).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
MG132 does not affect the overall growth of yeast cells.
(A) After incubation with different concentrations of MG132 for 2 h, ise1 cells were diluted 200-fold and then inoculated onto
YPD plates to determine the numbers of surviving colonies. (B) For
measurement of cell growth in the presence of 50 µM MG132 (up to
24 h) or with 0.1% DMSO (control), we took aliquots at the
indicated times and measured their optical densities at 600 nm
(OD600). Data shown here are the mean values ± SD
from three independent experiments.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 3.
MG132 increases thermotolerance in yeast cells. (A)
ise1 cells growing at 30°C were incubated with different
concentrations of MG132 or with 0.1% DMSO (control) for 2 h and
then exposed to 52°C for the indicated times. The cells were diluted
200-fold and plated onto YPD medium, and the fraction of viable cells
was measured as the number of colonies formed. (B) The ability to block
the breakdown of short-lived proteins by MG132 is proportional to its
ability to increase thermotolerance. Degradation of cell proteins after
5-min pulse-labeling with [35S]methionine was measured in
the presence or absence of MG132 as described previously
(32). (C) Time course for the increase in thermotolerance by
MG132. The ise1 cells were incubated at 30°C with or
without 50 µM MG132 for the indicated times. After exposure to
52°C, cell survival was measured. Data are mean values ± SD
from four independent experiments.
|
|
These findings indicate that the increases in hsp production are not
due to nonspecific toxic effects of the inhibitor; otherwise, growth
would have been reduced. This continued growth at normal rates in the
presence of the proteasome inhibitor was an unexpected finding, since
progression through multiple stages of the cell cycle requires
degradation of cyclins and other regulatory proteins by the
ubiquitin-proteasome pathway (7). Presumably, the residual activity of the proteasome under these conditions, which allowed protein degradation to proceed at 20% of the normal rate (Fig. 3B), is
sufficient for the selective degradation of these important proteins.
Inhibition of proteasome function induces thermotolerance.
To
test if exposure to proteasome inhibitors also increases the cells'
resistance to high temperatures, we incubated exponentially growing
ise1 cells at 30°C with different concentrations of MG132 for 2 h and then exposed them to 52°C for 5 to 20 min. To
measure the number of cells still viable and able to form colonies, the cells were then diluted 200-fold and plated in medium lacking the
inhibitor. After dilution of the treated cells, rates of protein breakdown should have returned to control level, since MG132 is a
reversible inhibitor, and its effects on proteolysis in vivo are
rapidly reversed upon removal of this inhibitor (31). After a 5-min exposure to 52°C, less than 0.1% of control cells could form
colonies. However, the cells incubated with MG132 showed 5- to
100-fold-greater survival, depending on the concentration used.
Similarly, after 20 min at 52°C, when less than 0.01% of control
cells survived, the MG132-treated cells showed 10- to 50-fold-higher
survival rates (Fig. 3A). The ise1 strain was two to three
times more sensitive to killing at 52°C than typical wild-type
strains (e.g., W303), presumably due to its defect in the biosynthesis
of principal membrane sterol (19). Nevertheless, MG132
caused a 50- to 100-fold increase in thermotolerance, such that this
mutant strain became much more resistant to high temperature than
wild-type cells. These results are also consistent with the finding for
mammalian cells, where this same inhibitor also increased thermotolerance dramatically (4).
If this response is signalled by the accumulation of nondegraded
proteins, it should depend on the degree of inhibition of protein
breakdown. Upon incubation with increasing concentrations of MG132, the
extent of inhibition of intracellular proteolysis increased, as did the
resistance of cells to high temperature (Fig. 3A). In fact, the number
of surviving cells increased almost in parallel with the extent of the
inhibition of intracellular protein breakdown (Fig. 3B). A significant
(about 10-fold) increase in thermotolerance was also seen when overall
proteolysis was reduced by only 20 to 30%, which corresponds to about
a 30 to 40% reduction in the proteasome-mediated breakdown of
short-lived proteins (since MG132 does not affect the vacuolar
degradation of long-lived proteins [31]).
If the development of thermotolerance results from the accumulation of
abnormal or short-lived proteins, this effect should also depend on the
duration of the inhibition of protein breakdown. To determine how the
length of the exposure to MG132 actually influences this response and
to learn how rapidly thermotolerance rises after the inhibitor is
added, we incubated ise1 cells with 50 µM MG132 for
different periods, shifted them to 52°C for 5 min, and measured cell
survival. Within an hour after MG132 addition, cell survival began to
rise and increased linearly with the duration of incubation for
up to 4 h, which was the longest time studied (Fig. 3C).
These findings support the conclusion that the rise in thermotolerance
was triggered by the accumulation of short-lived protein(s),
which would otherwise be rapidly degraded. The buildup of such a
short-lived regulatory component(s) would require continued protein
synthesis, and blocking synthesis by addition of cycloheximide (100 µg/ml) together with MG132 for 2 h prevented the rise in thermotolerance (Table 1). Alternatively,
this requirement for protein synthesis may also indicate that new
protective proteins have to be synthesized for the thermotolerant
state.
To confirm that the increase in thermotolerance induced by MG132 is
really due to the inhibition of protein breakdown by the proteasome, we
examined whether other proteasome inhibitors or inhibitors of other
cell proteases also could increase thermotolerance in ise1
cells. NAc-LLnLal (calpain inhibitor-1, MG101) is also a hydrophobic
peptide aldehyde but is a much weaker inhibitor of proteasomes than
MG132 (41), and in intact yeast, this agent does not block
protein degradation (31). Accordingly, incubation of cells
with this inhibitor (50 µM) did not induce thermotolerance (Fig.
4). The irreversible inhibitor
lactacystin covalently modifies the active-site threonine residues on
the proteasome's
subunits and thus blocks multiple peptidase
activities (14). However, lactacystin is quite impermeable
to yeast, even to ise1 cells, and therefore is ineffective
in reducing proteolysis in intact cells (31). As expected,
this agent did not enhance thermotolerance (Fig. 4). The active
derivative of lactacystin that actually reacts with the proteasome is
the spontaneous hydrolysis product, clasto-lactacystin
-lactone (11), which enters yeast cells readily
(31). Like MG132, the
-lactone is highly effective
in reducing the degradation of short-lived and abnormal polypeptides by
the ubiquitin-proteasome pathway (Fig. 4). Incubation of cells
for 2 h with the
-lactone (20 µM), which reduced proteolysis
by about 40%, increased cell survival 100-fold, similarly to MG132
(Fig. 4).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
The ability of different protease inhibitors to induce
thermotolerance and hsps correlates with their ability to inhibit
degradation of short-lived proteins. ise1 cells were
incubated with MG101 (50 µM), MG132 (50 µM), lactacystin (20 µM),
or -lactone (20 µM) for 2 h or PMSF (1 mM) for 2 to 24 h
and exposed to 52°C for 5 min, and then cell survival was measured.
In parallel, cells were pulse-labeled for 5 min with
[35S]methionine to measure the degradation of short-lived
proteins as described previously (32) and labeled for 30 min
to measure the content of hsp104 and Ydj1p as described for Fig. 1.
Data presented are the mean values + SD from three independent
experiments.
|
|
The inhibitors that increased cell survival at 52°C were also the
only ones that enhanced the expression of hsps. Like MG132, the
-lactone increased two- to threefold the expression of hsps, such as
hsp104 and Ydj1p, while the inhibitors that do not affect proteasome
function in intact yeast and did not increase thermotolerance (e.g.,
MG101 and lactacystin) also did not induce hsps (Fig. 4). Thus, the
ability of these agents to increase hsps and thermotolerance appears to
be directly related to their ability to inhibit proteasome function. We
also tested whether the effect of the
-lactone on thermotolerance,
like that of MG132, also depends on the duration of the inhibition.
Upon incubation for 1 to 2 h with the
-lactone, thermotolerance
increased progressively, and at 2 h, cell survival at 52°C was
20- to 100-fold higher than that in control cells. With longer
exposure, however, thermotolerance fell, and after 4 h, the cell
survival was similar to that of control (data not shown). Presumably
thermotolerance did not continue to increase with the
-lactone,
because it caused irreversible inhibition of proteasome function which
eventually blocked viability.
The bulk of cell proteins are long-lived components that are degraded
in yeast by the vacuolar system and not by the ubiquitin-proteasome pathway (31) (which degrades such proteins in mammalian
cells [41]). PMSF is a serine protease inhibitor which
inhibits multiple vacuolar proteases but not the proteasomes (12,
26). In growing yeast, this agent blocks vacuolar protein
breakdown and autophagic body formation (50) but does not
affect the breakdown of short-lived proteins (31). When
cells were treated with 1 mM PMSF for up to 24 h, no significant
effect on thermotolerance was seen (Fig. 4). Thus, this increase in
thermotolerance appears to be a specific consequence of the reduction
in degradation by the proteasomes of abnormal or short-lived, normal
proteins. The finding that inhibition of proteasome function leads to
an increased resistance to high temperature suggested that
certain mutant strains with defects in the 20S proteasome might also
show greater thermotolerance than wild-type cells. We therefore
examined thermotolerance of several mutant strains (kindly
provided by M. Hochstrasser), in which the active-site threonine
residues were mutated to alanines. A strain lacking the chymotryptic
activity exhibited severe defect in growth even at 30°C, and
therefore any effects seen upon heat shock and subsequently plating at
30°C could not be interpreted. However, the strain lacking the
tryptic site grew normally at 30°C and showed two- to threefold
greater survival at 52°C for 5 min than did isogenic wild type (data
not shown). While the results might support the present findings with
proteasome inhibitors, further experiments with these mutant strains
were not pursued since the use of selective inhibitors offered many
experimental advantages (e.g., the effects could be reversed or the
degree of inhibition could be altered).
Dissociation of thermotolerance from hsp production.
When yeast (or other) cells are preincubated at a high but not
lethal temperature (e.g., 37°C), hsps are induced, and a larger fraction of cells survive a subsequent exposure to 50°C than when they are switched directly from 28 to 50°C (39). If the
induction of hsps and induction of thermotolerance at 37°C are in
fact signalled by the generation of abnormal proteins, these effects
should be greater in the presence of proteasome inhibitors, which
prevent the rapid breakdown of such proteins. To test if the protective effects of preincubation at 37°C and proteasome inhibitors are additive or synergistic, we incubated exponentially growing
ise1 cells at 30°C with MG132 for 2 h and then
exposed them to 37°C for another 30 min prior to the shift to 52°C
for 5 to 20 min. As expected, incubation with either MG132 or 37°C
increased cell survival 10- to 50-fold (Fig.
5). However, the cells pretreated with
MG132 and then incubated at 37°C showed an additional 3- to
10-fold-greater survival than that induced by incubation at 37°C
alone (Fig. 5). As a result of the combined treatment, 25 to 30% of
cells survived exposure to 52°C for 10 min, while only 0.1% of
control cells did. Even after 20 min at 52°C, 8 to 10% of cells
preincubated with MG132 and 37°C survived, while less than 0.01% of
control cells and 1% of those preincubated only at 37°C were viable
(Fig. 5). Thus, these two stimuli are clearly synergistic in enhancing
thermotolerance.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 5.
Effects of combined exposure to MG132 and 37°C on
thermotolerance and the level of hsps. Exponentially growing
ise1 cells were preincubated for 2 h with 50 µM MG132
or with 0.1% DMSO (control). The cultures were then divided in half,
and one half was incubated at 37°C for an additional 30 min. The
cells were then exposed to 52°C for 5 to 20 min, and survival was
measured. In parallel, equal volumes of these cells were collected
before the exposure to 52°C, and their hsp104 and Ydj1p contents were
determined by Western blotting. For quantitation, the blots were
incubated with 125I-protein A for 2 h and subsequently
subjected to autoradiography. Data presented are the mean values ± SD from four independent experiments.
|
|
Additional experiments were carried out to test whether this marked
increase in cell survival, when 37°C and MG132 were combined, resulted from a similarly large increase in the synthesis of hsps. Since all hsps appeared to be induced in similarly by MG132 (Fig. 1),
we focused on hsp104 and Ydj1p, which are particularly important for
thermotolerance in yeast (5, 43) and showed large relative increases upon inhibitor treatment (Fig. 1). Surprisingly, the total
amount of these two hsps (assayed by Western blotting) in yeast treated
with both MG132 and 37°C was not significantly greater than that in
cells exposed to 37°C alone or incubated only with MG132 at 30°C,
despite their 3- to 10-fold greater survival at 52°C (Fig. 5). In
other words, these experiments failed to show additive effects on hsp
contents, and the dramatic increase in thermotolerance with the
combined treatment is not due to an increased content of these hsps.
These findings suggest that the increase in cell resistance to high
temperature is not simply due to the enhanced production of hsps. To
further examine the relationship between the expression of hsps and the
induction of thermotolerance, we studied the changes in both parameters
upon the removal of MG132. The inhibition of protein degradation by
MG132 is rapidly reversed upon inhibitor removal (31). We
therefore compared the changes in hsp production and the cells'
resistance to 52°C at different times after washing to remove MG132.
When the function of the proteasome was restored, yeast cells began to
lose thermotolerance very rapidly (with an apparent half-life of 30 min), and by 2 h, their ability to survive at 52°C was similar
to that of control cells (Fig. 6).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 6.
Effects of MG132 removal on thermotolerance and the
level of hsps. After a 2-h incubation with 50 µM MG132,
ise1 cells were washed with fresh medium to remove the
inhibitor. Half of the cells were then resuspended in medium containing
50 µM MG132 (MG132), and the other were incubated with 0.1% DMSO
alone (MG132 removed). These cells were incubated for an additional
2 h. At the indicated times, aliquots were taken and assayed for
resistance to 52°C for 5 min. In parallel, the contents of hsp104 and
Ydj1p in these aliquots were assayed by Western blotting as described
for Fig. 5. Data are mean values ± SD from four independent
experiments.
|
|
Surprisingly, after MG132 removal, there was no corresponding decrease
in the levels of hsp104 and of Ydj1p (as determined by Western
blotting). In fact, under this condition, production of these hsps
continued at a rate similar to that in the cells maintained in the
presence of MG132 (Fig. 6). Thus, after proteolysis was reinitiated,
thermotolerance fell rapidly, while the content of hsps remained high
and continued to increase for at least 2 h. Interestingly, a
similar rapid loss of thermotolerance without a loss of hsps has been
seen when heat-shocked yeast and bacterial cells are shifted back to
the normal temperature (6, 33). These results indicate that
blocking proteasome function leads to an increased cell resistance to
high temperature not simply through the induction of hsps but also
through some additional protection mechanism involving a short-lived
component.
Rapid accumulation of trehalose upon inhibition of proteasome
function.
One other molecule that has been shown to accumulate
during heat shock in yeast and other microorganisms is the nonreducing disaccharide trehalose (2, 10, 37). Moreover, its
accumulation has been shown to correlate with cellular resistance to
heat and dessication (2, 10, 37), and trehalose and hsp104
appear to have synergistic effect in protecting yeast cells from heat (13). As an attempt to identify additional mechanisms by
which proteasome inhibitors promote thermotolerance, we tested whether MG132 may cause an accumulation of trehalose in yeast. Upon incubation of growing ise1 cells with 50 µM MG132 at 30°C, the
level of trehalose in the cells increased markedly. After 3 h, a
two- to threefold increase in its level was observed (Fig.
7A). A similar buildup of trehalose was
seen when part of the culture was shifted from 30 to 37°C to induce
heat shock, in accord with prior reports (10, 13).
Furthermore, treatment of the cells with a highly specific and
irreversible inhibitor of the proteasome, clasto-lactacystin
-lactone, at a concentration (20 µM) that inhibited protein
breakdown by 40 to 50% (Fig. 4) caused an increase in the cellular
level of trehalose similar to that seen with MG132 (Table
2).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 7.
Effect of MG132 on the cellular content of trehalose.
(A) Exponentially growing ise1 cells were treated with or
without MG132 (50 µM) or incubated at 37°C. At indicated times,
aliquots of cells were collected and their trehalose contents were
measured. (B) After 2 h of incubation with MG132 (50 µM), the
inhibitor was removed by washing cells with fresh medium. These cells
were then resuspended in the medium without MG132 and further incubated
for 2 h. At the given times, cells were collected and trehalose
contents were measured. Data are mean values ± SD from three
independent experiments.
|
|
These observations with the
-lactone confirmed that the buildup of
the disaccharide was a specific consequence of the inhibition of
proteasome function and not any nonspecific effect of MG132. Moreover,
when the reversible inhibitor MG132 was removed from the medium,
the cellular level of trehalose decreased very quickly, and after
1 h, almost no trehalose was detected (Fig. 7B). Thus, its content
fell (unlike that of hsps) under conditions where thermotolerance also
decreased rapidly (Fig. 6). In addition, when cells were exposed to
MG132 and 37°C together, the content of trehalose increased to higher
levels than in cells exposed only to 37°C or incubated only with
MG132 at 30°C (Fig. 8). In fact,
increasing temperature and MG132 had either additive or synergistic
effects (depending on the experiment) in causing accumulation of
trehalose.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 8.
Effect of combined exposure to MG132 and 37°C on the
cellular content of trehalose. Exponentially growing ise1
cells were preincubated for 2 h with 50 µM MG132 or with 0.1%
DMSO (control). The cultures were then divided in half, and one half
was incubated at 37°C for an additional 30 min. After collecting
cells by centrifugation, we measured the cellular level of trehalose.
Data presented are the mean values ± SD from three independent
experiments.
|
|
These observations together strongly suggest that trehalose is the
short-lived metabolite which is essential for thermotolerance induced
upon exposure to proteasome inhibitors: (i) it has thermoprotective effects, (ii) it accumulates when protein breakdown is inhibited, (iii)
its cellular content, unlike that of hsps, decreases rapidly after
MG132 removal (when proteolysis is reinitiated), and (iv) its level is
closely correlated with thermotolerance when cells are exposed to the
inhibitor and 37°C together.
 |
DISCUSSION |
Mechanism of induction of hsps and thermotolerance.
A common
feature of the diverse conditions that elicit the heat shock response
is that they cause damage to cell proteins. The present findings
provide further strong evidence that the accumulation of such abnormal
proteins signals this response (1, 17, 22, 40). We found
that inhibition of proteasome function by MG132 or the
-lactone,
which prevents the rapid degradation of abnormal proteins, causes
induction of all four hsps tested and a dramatic increase in
thermotolerance. The magnitude of the increase in cell survival at
52°C was directly proportional to the degree of inhibition of protein
breakdown and its duration (Fig. 3). Similar effects were seen in
studies with a mutant strain in which one of the peptidase activities
of the proteasome is inactivated (data not shown). Furthermore, no such
effects were seen with protease inhibitor that did not block protein
breakdown by the proteasome (e.g., inhibitor of the vacuolar proteases) (Fig. 4). Also, high temperatures, which should cause damage to cell
proteins, and MG132, which reduces their degradation, had synergistic
effects in promoting thermotolerance (Fig. 6).
In almost all eukaryotic and prokaryotic cells, the heat shock response
is elicited by very similar stimuli. In Escherichia coli,
inhibition of protein breakdown also causes induction of hsps
(17), and in related studies, we have found that treatment of MDCK cells with MG132 or lactacystin leads to a rapid induction of
multiple hsps and to thermotolerance (4). In addition, in several human cell lines, these inhibitors cause an induction of hsps
via a specific activation of heat shock transcription factor 2 (34). A marked increase in hsp70 was also recently found in
HepG2 cells treated with proteasome inhibitors (52). These
inhibitors are now widely used by cell biologists, immunologists, and
biochemists to analyze the functions of the proteasome in vivo. The
present finding may complicate the interpretation of experiments using
these inhibitors, especially in long-term studies of intact cells,
where possible indirect effects due to induction of hsps clearly have
to be considered.
Exactly how the proteasome inhibitors stimulate transcription of hsps
is unclear. The simplest mechanism would be that they cause abnormal
proteins to build up and saturate the cells' degradative machinery,
resulting in a failure of the cell to degrade a critical short-lived,
positive regulator of transcription of hsps. A similar model has been
shown to activate the transcription of hsps in E. coli
(16). Their expression is regulated by a specific component of RNA polymerase,
32. This positive regulator is
normally degraded with a half-life of 2 to 3 min, but is stabilized
manyfold during heat shock. The rapid degradation of
32
requires both the FtsH protease and the molecular chaperones DnaK (an
hsp70 homolog) and its cofactors DnaJ and GrpE. During heat shock,
unfolded polypeptides accumulate and saturate the binding capacity of
these chaperones, leading to reduced breakdown of
32 and
enhanced transcription of hsps (16). In eukaryotic cells, no
such short-lived regulator of hsps transcription has yet been found,
although such a regulator of heat shock transcription factor 2 appears
to exist and to respond to the level of abnormal proteins (34).
Dissociation of thermotolerance from induction of hsps.
Induction of hsps has been generally assumed to lead to
thermotolerance, especially since most hsps are either molecular
chaperones which can help prevent protein aggregation and promote
refolding or components of the degradative system (e.g., ubiquitin and
ubiquitin-conjugating enzymes) which help eliminate such irreversibly
damaged polypeptides at high temperatures. Treatment with proteasome
inhibitors, while inducing hsps, increased up to 100-fold cell survival
at 52°C. Under these conditions, we also have found a marked increase
in cellular resistance to other toxic insults (e.g., high concentration of ethanol or oxygen radicals) (data not shown). However, the cellular
content of hsps did not correlate with thermotolerance, even though
both responses appear to result from the same physiological signals.
The dissociation of these two responses was most dramatic after removal
of MG132 when the cells' resistance to heat and oxygen radicals fell
rapidly, while hsp production continued to increase (presumably due to
the stability of hsps and their mRNAs). In addition, when yeast cells
were exposed to both 37°C and MG132, these stimuli had synergistic
effects in increasing cell survival, even though hsp content did not
increase appreciably above levels seen with either stimulus alone.
Thus, some component, in addition to hsps, is necessary for tolerance
to heat.
This conclusion is consistent with several prior studies suggesting
that heat shock-induced thermotolerance can be dissociated from hsp
synthesis. For example, an increase in thermotolerance can be induced
in yeast by incubation at 37°C even when protein synthesis is blocked
(20) and in a yeast mutant which lacks the heat
shock-specific transcription factor (48). In addition, upon
down-shift of heat-shocked yeast or bacterial cells to 23°C, thermotolerance is lost within 1 to 2 h, even though the amounts of hsps do not fall (6, 33). Thus, proteasome inhibitors, like heat treatment, elicit two protective responses. First, there is
an increase in expression of hsps, which presumably is important for
the enhanced viability at 52°C. Accordingly, cycloheximide treatment
blocked the ability of MG132 to increase thermotolerance (although
alternative interpretations of cycloheximide's effect may be
possible). Second, an additional adaptation is essential for the
increase in thermotolerance. This factor must be short-lived since the
resistance to heat decreased to control level within 30 min after
protein breakdown was reinitiated. Recently, a short-lived transcription factor, Hac1p, that is required for the unfolded protein
response in the ER has been identified (9). Normally, Hac1p
is rapidly degraded by the ubiquitin-proteasome pathway, but when
abnormal proteins accumulate in the ER, a more stable transcription
factor is produced by alternative splicing (9). Perhaps a
similar short-lived regulator functions in the cytosol or nucleus and
is critical for thermotolerance.
Possibly, the rapid fall in thermotolerance when the proteasome
inhibitor was removed indicates that this state requires protein phosphorylation or some other reversible modification, which occurs when protein degradation decreases and abnormal proteins accumulate. Several protein kinases have been reported to be activated by heat
shock (27, 30), and perhaps they are also activated when the
proteasomes are inhibited. A membrane-associated protein kinase is
activated by the accumulation of unfolded proteins in the ER and plays
a role in the induction of ER chaperones (8, 35). Another
possible way that protein phosphorylation might enhance thermotolerance
is evident in E. coli, where upon heat shock, the major
chaperones, DnaK and GroEL, undergo reversible phosphorylation, and
this modification markedly enhances their affinity for unfolded proteins (46). Possibly, chaperone function is regulated
similarly during heat shock in eukaryotic cells so as to enhance
resistance to high temperatures.
Involvement of trehalose in the induced thermotolerance.
The
present findings favor a simpler explanation, i.e., that the resistance
to high temperatures requires a short-lived, small molecule,
specifically, trehalose, which has thermoprotective effects and
accumulates when protein breakdown is inhibited. Several conditions
that induce the heat shock response in S. cerevisiae have
been found to also cause a buildup of trehalose, in part by stimulating
the expression of enzymes for trehalose biosynthesis (13, 23,
37). Furthermore, the time course of the accumulation of
trehalose upon heat shock and the decline in its level following the return to the normal temperature paralleled the changes in thermotolerance (2). In the present study, we have shown
that trehalose rapidly accumulates in cells, when the function of the proteasome is inhibited by treatment either with MG132 or with the specific, irreversible proteasome inhibitor, the
-lactone. It is
noteworthy that very similar results were obtained with these
structurally unrelated types of inhibitors. MG132 is a reversible peptide aldehyde that functions as a substrate analog, and the
-lactone is an irreversible inhibitor that covalently modifies 20S
proteasome's active site threonine and no other cell protein (14). Together these observations confirm that the buildup
of trehalose was a specific consequence of the inhibition of proteasome function in the cells. Moreover, the cellular content of this disaccharide correlated closely with changes in viability at 52°C, unlike the cells' content of hsps. Upon removal of the inhibitor and
restoration of protein breakdown, the levels of trehalose fell
dramatically within 30 min, as did cell resistance to high temperatures. In addition, heat shock (37°C) and MG132 had
additive or synergistic effects in raising trehalose content and
thermotolerance. Under these same conditions, the content of hsps did
not correlate with thermotolerance.
It has been suggested that trehalose and molecular chaperones,
especially hsp104, function synergistically to enhance thermotolerance in yeast in stationary phase (13). Moreover, in vitro
studies have shown that trehalose can stabilize certain proteins
against heat inactivation (24), while the various chaperones
can help prevent the aggregation of a damaged polypeptide and help
refold or resolubilize denatured proteins (39). Thus, the
expression of hsps and the accumulation of trehalose appear to be
complementary protective responses. By simultaneously inducing both,
the proteasome inhibitors appear to enhance cell resistance to heat and
other toxic insults that irreversibly damage cell proteins and cause cell death.
Because induction of the heat shock response can protect tissues
against a variety of toxic conditions, including anoxia and reperfusion
injury, there has been appreciable interest in the possible
applications of this response in medicine. Like heat treatment, the
proteasome inhibitors can cause an induction of thermotolerance not
only in yeast cells but also in mammalian cells, where these agents
also cause induction of ER chaperones (4), which also help
protect cells against anoxic injury. These findings together suggest
that proteasome inhibitors may be an effective and relatively nontoxic
way to elicit these protective responses, in contrast to other inducers
of this response, such as high temperatures or incorporation of amino
acid analogs or heavy metals, all of which can be highly
damaging and therefore are probably not appropriate for
therapeutic use in patients. Moreover, when the proteasome inhibitors
are combined with these other stimuli, they have synergistic effects in
protecting cells. Greater understanding of the molecular mechanisms by
which these inhibitors promote resistance to high temperatures and
other toxic insults may lead to practical applications of these
inhibitors in medicine, agriculture, or biotechnology.
 |
ACKNOWLEDGMENTS |
We thank Proscript, Inc. (Cambridge, Mass.), and S. Omura for
providing MG101, MG132, the
-lactone, and lactacystin and S. Lindquist, M. Douglas, K. A. Arndt, M. H. Hochstrasser,
and J. C. Wang for supplying antibodies and yeast strains.
This study was supported by grants from the National Institute of
Health (NIGMS), the Human Frontier Science Program, and Proscript, Inc.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Cell Biology, Harvard Medical School, 25 Shattuck St., Boston, MA
02115. Phone: (617) 432-1855. Fax: (617) 232-0173. E-mail:
agoldber{at}bcmp.med.harvard.edu.
 |
REFERENCES |
| 1.
|
Ananthan, J.,
A. L. Goldberg, and R. Voellmy.
1986.
Abnormal proteins serve as eukaryotic stress signals and trigger the activation of heat shock genes.
Science
232:522-524[Abstract/Free Full Text].
|
| 2.
|
Attfield, P. V.
1987.
Trehalose accumulates in Saccharomyces cerevisiae during exposure to agents that induce heat shock response.
FEBS Lett.
225:259-263[Medline].
|
| 3.
|
Barnes, C. A.,
G. C. Johnston, and R. A. Singer.
1990.
Thermotolerance is independent of induction of the full spectrum of heat shock proteins and of cell cycle blockage in the yeast Saccharomyces cerevisiae.
J. Bacteriol.
172:4352-4358[Abstract/Free Full Text].
|
| 4.
|
Bush, K.,
A. L. Goldberg, and S. Nigam.
1997.
Proteasome inhibition leads to a heat shock response, induction of endoplasmic reticulum chaperones and thermotolerance.
J. Biol. Chem.
272:9086-9092[Abstract/Free Full Text].
|
| 5.
|
Caplan, A. J.,
D. M. Cyr, and M. G. Douglas.
1993.
Eukaryotic homologues of Escherichia coli dnaJ: a diverse protein family that functions with hsp70 stress proteins.
Mol. Biol. Cell
4:555-563[Medline].
|
| 6.
|
Cavicchioli, R., and K. Watson.
1986.
Loss of heat-shock acquisition of thermotolerance in yeast is not correlated with loss of heat-shock proteins.
FEBS Lett.
207:149-152[Medline].
|
| 7.
|
Ciechanover, A.
1994.
The ubiquitin-proteasome proteolytic pathway.
Cell
79:13-21[Medline].
|
| 8.
|
Cox, J. S.,
C. E. Shamu, and P. Walter.
1993.
Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase.
Cell
73:1197-1206[Medline].
|
| 9.
|
Cox, J. S., and P. Walter.
1996.
A novel mechanism for regulating activity of a transcription factor that controls the unfolded protein response.
Cell
87:391-404[Medline].
|
| 10.
|
De Virgilio, C.,
T. Hottiger,
J. Dominguez,
T. Boller, and A. Wiemken.
1993.
The role of trehalose synthesis for the acquisition of thermotolerance in yeast. I. Genetic evidence that trehalose is a thermoprotectant.
Eur. J. Biochem.
219:179-186[Medline].
|
| 11.
|
Dick, L. R.,
A. A. Cruikshank,
A. T. Destree,
L. Grenier,
T. A. McCormack,
F. D. Melandri,
S. L. Nunes,
V. J. Palombella,
L. A. Parent,
L. Plamondon, and R. L. Stein.
1997.
Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells.
J. Biol. Chem.
272:182-188[Abstract/Free Full Text].
|
| 12.
|
Dubiel, W.,
G. Pratt,
K. Ferrell, and M. Rechsteiner.
1992.
Purification of an 11S regulator of the multicatalytic protease.
J. Biol. Chem.
267:22369-22377[Abstract/Free Full Text].
|
| 13.
|
Elliot, B.,
R. S. Haltiwanger, and B. Futcher.
1996.
Synergy between trehalose and hsp104 for thermotolerance in Saccharomyces cerevisiae.
Genetics
144:923-933[Abstract].
|
| 14.
|
Fenteany, G.,
R. F. Standaert,
W. S. Lane,
S. Choi,
E. J. Corey, and S. L. Schreiber.
1995.
Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
Science
268:726-731[Abstract/Free Full Text].
|
| 15.
|
Georgopoulos, C., and W. J. Welch.
1993.
Role of the major heat shock proteins as molecular chaperones.
Annu. Rev. Cell Biol.
9:601-634.
|
| 16.
|
Georgopoulos, C.,
K. Liberek,
M. Zylicz, and D. Ang.
1994.
Properties of the heat shock proteins of Escherichia coli and the autoregulation of the heat shock response, p. 209-249. In
R. I. Morimoto, A. Tissieres, and A. Georgopoulos (ed.), The biology of heat shock proteins and molecular chaperones.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 17.
|
Goff, S. A., and A. L. Goldberg.
1985.
Production of abnormal proteins in E. coli stimulates transcription of lon and other heat shock genes.
Cell
41:587-595[Medline].
|
| 18.
|
Goldberg, A. L.,
R. Stein, and J. Adams.
1995.
New insights into proteasome function: from archaebacteria to drug development.
Chem. Biol.
2:503-508.
[Medline] |
| 19.
|
Graham, T. R.,
P. A. Scott, and S. D. Emr.
1993.
Brefeldin A reversibly blocks early but not late protein transport steps in the yeast secretory pathway.
EMBO J.
12:869-877[Medline].
|
| 20.
|
Gross, C., and K. Watson.
1996.
Heat shock protein synthesis and trehalose accumulation are not required for induced thermotolerance in depressed Saccharomyces cerevisiae.
Biochem. Biophys. Res. Commun.
220:766-772[Medline].
|
| 21.
|
Hendricks, J. P., and F.-U. Hartl.
1993.
Molecular chaperone functions of heat shock proteins.
Annu. Rev. Biochem.
62:349-384[Medline].
|
| 22.
|
Hightower, L. E.
1980.
Cultured animal cells exposed to amino acid analogues or puromycin rapidly synthesize several polypeptides.
J. Cell. Physiol.
102:407-424[Medline].
|
| 23.
|
Hottiger, T.,
C. De Virgilio,
W. Bell,
T. Boller, and A. Wiemken.
1992.
The 70-kilodalton heat-shock proteins of the SSA subfamily negatively modulate heat-shock-induced accumulation of trehalose and promote recovery from heat stress in the yeast, Saccharomyces cerevisiae.
Eur. J. Biochem.
210:125-132[Medline].
|
| 24.
|
Hottiger, T.,
C. De Virgilio,
M. N. Hall,
T. Boller, and A. Wiemken.
1994.
The role of trehalose synthesis for the acquisition of thermotolerance in yeast. II. Physiological concentrations of trehalose increase the thermal stability of proteins in vitro.
Eur. J. Biochem.
219:187-193[Medline].
|
| 25.
|
Jensen, T. J.,
M. A. Loo,
S. Pind,
D. B. Williams,
A. L. Goldberg, and J. R. Riordan.
1995.
Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.
Cell
83:129-135[Medline].
|
| 26.
|
Jones, E. W.
1991.
Tackling the protease problem in Saccharomyces cerevisiae.
Methods Enzymol.
194:428-453[Medline].
|
| 27.
|
Kamada, Y.,
U. S. Jung,
J. Piotrowski, and D. E. Levin.
1995.
The protein kinase C-activated MAP kinase pathway of Saccharomyces cerevisiae mediates a novel aspect of the heat shock response.
Genes Dev.
9:1559-1571[Abstract/Free Full Text].
|
| 28.
|
Kandror, O.,
L. Busconi,
M. Y. Sherman, and A. L. Goldberg.
1994.
Rapid degradation of an abnormal protein in Escherichia coli involves the chaperone groEL and groES.
J. Biol. Chem.
269:23575-23582[Abstract/Free Full Text].
|
| 29.
|
Kienle, I.,
M. Burgert, and H. Holtzer.
1993.
Assay of trehalose with acid trehalase purified from Saccharomyces cerevisiae.
Yeast
9:607-611[Medline].
|
| 30.
|
Kyriakis, J. M., and J. Avruch.
1996.
Protein kinase cascades activated by stress and inflammatory cytokines.
BioEssays
18:567-577[Medline].
|
| 31.
|
Lee, D. H., and A. L. Goldberg.
1996.
Selective inhibitors of the proteasome-dependent and vacuolar pathways in Saccharomyces cerevisiae.
J. Biol. Chem.
271:27280-27284[Abstract/Free Full Text].
|
| 32.
|
Lee, D. H.,
M. Y. Sherman, and A. L. Goldberg.
1996.
Involvement of the molecular chaperone Ydj1 in the ubiquitin-dependent degradation of short-lived and abnormal proteins in Saccharomyces cerevisiae.
Mol. Cell. Biol.
16:4773-4781[Abstract].
|
| 33.
|
Mackey, B. M., and C. Derrick.
1990.
Heat shock protein synthesis and thermotolerance in Salmonella typhimurium.
J. Appl. Bacteriol.
69:373-383[Medline].
|
| 34.
| Mathew, A., S. K. Mathur, and R. I. Morimoto. Personal communication.
|
| 35.
|
Mori, K.,
W. Ma,
M.-J. Gething, and J. Sambrook.
1993.
A transmembrane protein with a cdc2+/CDC28-related kinase activity is required for signaling from ER to the nucleus.
Cell
74:743-756[Medline].
|
| 36.
|
Nagata, K.
1996.
Regulation of thermotolerance and ischemic tolerance, p. 467-481. In
U. Feige, R. I. Morimoto, I. Yahara, and B. S. Polla (ed.), Stress-inducible cellular responses.
Birkhauser, Basel, Switzerland.
|
| 37.
|
Neves, M.-J., and J. Francois.
1992.
On the mechanism by which a heat shock induces trehalose accumulation in Saccharomyces cerevisiae.
Biochem. J.
288:859-864.
|
| 38.
|
Nitiss, J., and J. C. Wang.
1988.
DNA topoisomerase-targeting antitumor drugs can be studied in yeast.
Proc. Natl. Acad. Sci. USA
85:7501-7505[Abstract/Free Full Text].
|
| 39.
|
Parsell, D. A., and S. Lindquist.
1994.
Heat shock proteins and stress tolerance, p. 457-494. In
R. I. Morimoto, A. Tissieres, and A. Georgopoulos (ed.), The biology of heat shock proteins and molecular chaperones.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 40.
|
Parsell, D. A., and R. T. Sauer.
1989.
Induction of heat shock-like response by unfolded protein in Escherichia coli: dependence on protein level not protein degradation.
Genes Dev.
3:1226-1232[Abstract/Free Full Text].
|
| 41.
|
Rock, K. L.,
C. Gramm,
L. Rothstein,
K. Clark,
R. Stein,
L. Dick,
D. Hwang, and A. L. Goldberg.
1994.
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.
Cell
78:761-771[Medline].
|
| 42.
|
Ruis, H., and C. Schüller.
1995.
Stress signaling in yeast.
BioEssays
17:959-965[Medline].
|
| 43.
|
Sanchez, Y., and S. Lindquist.
1990.
Hsp104 required for induced thermotolerance.
Science
248:1112-1115[Abstract/Free Full Text].
|
| 44.
|
Sanchez, Y.,
D. A. Parsell,
J. Taulien,
J. L. Vogel,
E. A. Craig, and S. Lindquist.
1993.
Genetic evidence for a functional relationship between hsp104 and hsp70.
J. Bacteriol.
175:6484-6491[Abstract/Free Full Text].
|
| 45.
|
Seufert, W., and S. Jentsch.
1990.
Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate selective degradation of short-lived and abnormal proteins.
EMBO J.
9:543-550[Medline].
|
| 46.
|
Sherman, M. Y., and A. L. Goldberg.
1993.
Heat shock of Escherichia coli increases binding of dnaK (the hsp70 homolog) to polypeptides by promoting its phosphorylation.
Proc. Natl. Acad. Sci. USA
90:8648-8652[Abstract/Free Full Text].
|
| 47.
|
Sherman, M. Y., and A. L. Goldberg.
1996.
Involvement of molecular chaperones in intracellular protein breakdown, p. 57-78. In
U. Feige, R. I. Morimoto, I. Yahara, and B. S. Polla (ed.), Stress-inducible cellular responses.
Birkhauser, Basel, Switzerland.
|
| 48.
|
Smith, B. J., and M. P. Yaffe.
1991.
Uncoupling thermotolerance from the induction of heat shock proteins.
Proc. Natl. Acad. Sci. USA
88:11091-11094[Abstract/Free Full Text].
|
| 49.
|
Storz, G., and B. S. Polla.
1996.
Transcriptional regulators of oxidative stress-inducible genes in prokaryotes and eukaryotes, p. 239-254. In
U. Feige, R. I. Morimoto, I. Yahara, and B. S. Polla (ed.), Stress-inducible cellular responses.
Birkhauser, Basel, Switzerland.
|
| 50.
|
Takeshige, K.,
M. Baba,
S. Tsuboi,
T. Noda, and Y. Ohsumi.
1992.
Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction.
J. Cell Biol.
119:301-311[Abstract/Free Full Text].
|
| 51.
|
Welch, W. J.
1992.
Mammalian stress response: cell physiology, structure/function of stress proteins and implications for medicine and disease.
Physiol. Rev.
72:1063-1081[Free Full Text].
|
| 52.
|
Zhou, M.,
X. Wu, and H. N. Ginsberg.
1996.
Evidence that a rapidly turning over protein, normally degraded by proteasomes, regulates hsp72 gene transcription in HepG2 cells.
J. Biol. Chem.
271:24769[Abstract/Free Full Text].
|
Mol Cell Biol, January 1998, p. 30-38, Vol. 18, No. 1
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yamamoto, N., Maeda, Y., Ikeda, A., Sakurai, H.
(2008). Regulation of Thermotolerance by Stress-Induced Transcription Factors in Saccharomyces cerevisiae. Eukaryot Cell
7: 783-790
[Abstract]
[Full Text]
-
Yu, P., Kodadek, T.
(2007). Dynamics of the Hypoxia-inducible Factor-1-Vascular Endothelial Growth Factor Promoter Complex. J. Biol. Chem.
282: 35035-35045
[Abstract]
[Full Text]
-
Naik, S., Piwnica-Worms, D.
(2007). Real-time imaging of beta-catenin dynamics in cells and living mice. Proc. Natl. Acad. Sci. USA
104: 17465-17470
[Abstract]
[Full Text]
-
Fu, D., Richardson, D. R.
(2007). Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion. Blood
110: 752-761
[Abstract]
[Full Text]
-
Li, C., Wu, R.-C., Amazit, L., Tsai, S. Y., Tsai, M.-J., O'Malley, B. W.
(2007). Specific Amino Acid Residues in the Basic Helix-Loop-Helix Domain of SRC-3 Are Essential for Its Nuclear Localization and Proteasome-Dependent Turnover. Mol. Cell. Biol.
27: 1296-1308
[Abstract]
[Full Text]
-
Yoo, C. Y., Miura, K., Jin, J. B., Lee, J., Park, H. C., Salt, D. E., Yun, D.-J., Bressan, R. A., Hasegawa, P. M.
(2006). SIZ1 Small Ubiquitin-Like Modifier E3 Ligase Facilitates Basal Thermotolerance in Arabidopsis Independent of Salicylic Acid. Plant Physiol.
142: 1548-1558
[Abstract]
[Full Text]
-
Yu, L., Mohamed, A. J., Vargas, L., Berglof, A., Finn, G., Lu, K. P., Smith, C. I. E.
(2006). Regulation of Bruton Tyrosine Kinase by the Peptidylprolyl Isomerase Pin1. J. Biol. Chem.
281: 18201-18207
[Abstract]
[Full Text]
-
Uryu, K., Richter-Landsberg, C., Welch, W., Sun, E., Goldbaum, O., Norris, E. H., Pham, C.-T., Yazawa, I., Hilburger, K., Micsenyi, M., Giasson, B. I., Bonini, N. M., Lee, V. M.-Y., Trojanowski, J. Q.
(2006). Convergence of Heat Shock Protein 90 with Ubiquitin in Filamentous {alpha}-Synuclein Inclusions of {alpha}-Synucleinopathies. Am. J. Pathol.
168: 947-961
[Abstract]
[Full Text]
-
Awasthi, N., Wagner, B. J.
(2005). Upregulation of Heat Shock Protein Expression by Proteasome Inhibition: An Antiapoptotic Mechanism in the Lens. IOVS
46: 2082-2091
[Abstract]
[Full Text]
-
Guerra, E., Chye, P. P., Berardi, E., Piper, P. W.
(2005). Hypoxia abolishes transience of the heat-shock response in the methylotrophic yeast Hansenula polymorpha. Microbiology
151: 805-811
[Abstract]
[Full Text]
-
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., Libermann, T. A., Treon, S. P., Munshi, N. C., Richardson, P. G., Hideshima, T., Anderson, K. C.
(2002). Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc. Natl. Acad. Sci. USA
99: 14374-14379
[Abstract]
[Full Text]
-
Cheng, I. H., Roberts, L. A., Tye, B. K.
(2002). Mcm3 Is Polyubiquitinated during Mitosis before Establishment of the Pre-replication Complex. J. Biol. Chem.
277: 41706-41714
[Abstract]
[Full Text]
-
Lin, H.-K., Altuwaijri, S., Lin, W.-J., Kan, P.-Y., Collins, L. L., Chang, C.
(2002). Proteasome Activity Is Required for Androgen Receptor Transcriptional Activity via Regulation of Androgen Receptor Nuclear Translocation and Interaction with Coregulators in Prostate Cancer Cells. J. Biol. Chem.
277: 36570-36576
[Abstract]
[Full Text]
-
Hofmann, G. E., Buckley, B. A., Place, S. P., Zippay, M. L.
(2002). Molecular Chaperones in Ectothermic Marine Animals: Biochemical Function and Gene Expression. Integr. Comp. Biol.
42: 808-814
[Abstract]
[Full Text]
-
Kandror, O., DeLeon, A., Goldberg, A. L.
(2002). Trehalose synthesis is induced upon exposure of Escherichia coli to cold and is essential for viability at low temperatures. Proc. Natl. Acad. Sci. USA
99: 9727-9732
[Abstract]
[Full Text]
-
Luss, H., Schmitz, W., Neumann, J.
(2002). A proteasome inhibitor confers cardioprotection. Cardiovasc Res
54: 140-151
[Abstract]
[Full Text]
-
Gouesbet, G., Jan, G., Boyaval, P.
(2002). Two-Dimensional Electrophoresis Study of Lactobacillus delbrueckii subsp. bulgaricus Thermotolerance. Appl. Environ. Microbiol.
68: 1055-1063
[Abstract]
[Full Text]
-
Fleming, J. A., Lightcap, E. S., Sadis, S., Thoroddsen, V., Bulawa, C. E., Blackman, R. K.
(2002). Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341. Proc. Natl. Acad. Sci. USA
99: 1461-1466
[Abstract]
[Full Text]
-
Shinohara, M. L., Correa, A., Bell-Pedersen, D., Dunlap, J. C., Loros, J. J.
(2002). Neurospora Clock-Controlled Gene 9 (ccg-9) Encodes Trehalose Synthase: Circadian Regulation of Stress Responses and Development. Eukaryot Cell
1: 33-43
[Abstract]
[Full Text]
-
Wang, E. W., Kessler, B. M., Borodovsky, A., Cravatt, B. F., Bogyo, M., Ploegh, H. L., Glas, R.
(2000). Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity. Proc. Natl. Acad. Sci. USA
10.1073/pnas.180328897v1
[Abstract]
[Full Text]
-
Pirkkala, L., Alastalo, T.-P., Zuo, X., Benjamin, I. J., Sistonen, L.
(2000). Disruption of Heat Shock Factor 1 Reveals an Essential Role in the Ubiquitin Proteolytic Pathway. Mol. Cell.